Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

14 May 2012 11:02

Matrix Income & Growth VCT plc (the Company) INTERIM MANAGEMENT STATEMENT For the quarter ended 31 March 2012

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UKListing Authority, Matrix Income & Growth VCT plc presents an InterimManagement Statement for the quarter ended 31 March 2012. The statement alsoincludes relevant financial information between the end of the period and thedate of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2012 At 31 December

2011

Net assets attributable to shareholders £41,915,672 £40,726,175 Shares in issue 43,444,512 42,606,052 Net asset value per Ordinary Share 96.48 p 95.59 p Cumulative dividends paid 26.80 p 26.80 p Total return (net asset value basis) 123.28 p 122.39 pper share since inception % return on opening net asset value 30.46 % 29.51 %per share of 94.5 pence

The net asset value per share has risen by 0.89 pence over the quarter. This is primarily due to a positive income return in the quarter.

CUMULATIVE DIVIDENDS

A final dividend of 6.25 pence per share comprising 1.25 pence from income and5.00 pence from capital in respect of the year ended 31 December 2011 wasapproved by shareholders at the Annual General Meeting of the Company held on10 May 2012. The dividend will be payable on 22 May 2012 to Shareholders whoare on the Register on 11 May 2012. This dividend, once paid, will increasecumulative dividends paid since inception to 33.05 pence per share.

NEW INVESTMENTS

The Company continued its Operating Partner programme, which resulted in further new investment in the quarter of £4 million, with a further £3 million invested after the quarter-end.

LOAN STOCK REPAYMENTS

In January, Fullfield Limited made a partial repayment of its loan stock of

£122,692 and Focus Pharma Holdings Limited repaid £269,708 of its loan stock, together with a premium of £121,045.

SHARE BUYBACKS

The Company bought back 925,000 of its own Ordinary Shares at an average priceof 82.78 pence during the quarter ended 31 March 2012. Since the end of theperiod, it has bought back a further 247,320 of its own shares at a price of85.84 pence.

MATRIX VCTs' LINKED OFFER FOR SUBSCRIPTION

During the quarter ended 31 March 2012, the Company issued and allotted a total of 1,763,460 ordinary shares at a price of £1.012 per share, raising net proceeds of £1,690,204 (after deducting initial costs).

Since the quarter end the Company has allotted a further 3,118,113 ordinary shares at a price of £1.012 per share, raising further net proceeds of £2,985,810 (after deducting initial costs).

Applications totalling £14.5 million have been received to date under the Offer of which £4.8 million has been received for Matrix Income & Growth VCT plc.

The Offer remains open until 30 June 2012.

For further information, please contact:

Sarah Penfold, for Matrix Private Equity Partners LLP, Company Secretary: 020 3206 7000.

XLON
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20252:00 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
5th Mar 20256:01 pmRNSResult of AGM
5th Mar 20253:55 pmRNSInterim Management Statement
5th Mar 202512:25 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20254:00 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20252:00 pmRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20254:06 pmRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
28th Oct 20242:05 pmRNSDirector/PDMR Shareholding
28th Oct 20242:00 pmRNSIssue of Equity and Total Voting Rights
15th Oct 202411:15 amRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:00 amRNSIssue of Equity
26th Sep 20249:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20241:06 pmRNSHalf-year Report
18th Sep 202410:00 amRNSOffer for Subscription – Update
2nd Sep 20243:15 pmRNSOffer for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:32 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:42 amRNSTotal Voting Rights and Capital
18th Jun 20245:30 pmRNSPROPOSED MERGER AND OFFERS
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
28th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20245:34 pmRNSResult of Annual General Meeting
20th May 20247:00 amRNSInterim Management Statement
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSDividend Declaration
15th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
1st Feb 202411:46 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202312:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.